Skip to search.
 All Ordinaries Down 0.43%

Athersys, Inc. (ATHX)

-NasdaqCM
1.92 Down 0.04(2.04%) 27 Aug 06:00
Prev Close:1.96
Open:1.94
Bid:1.79 x 1000
Ask:2.10 x 100
1y Target Est:7.00
Beta:-0.892196
Next Earnings Date: 3-Nov-16ATHX Earnings announcement
Day's Range:1.91 - 2.00
52wk Range:0.94 - 2.90
Volume:200,422
Avg Vol (3m):516,622
Market Cap:163.17M
P/E (ttm):N/A
EPS (ttm):-0.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ATHXDown 2.04%163.17M
OSIRDown 1.19%171.92M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.22
Quarterly EPS Est (Sep-16) :-0.10
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback